CV Sciences (CVSI) EPS (Basic) Growth (5y) (2016 - 2026)
CV Sciences (CVSI) EPS (Basic) Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.09% |
| Mar 31, 2026 | 35.12% |
| Dec 31, 2025 | 14.98% |
| Sep 30, 2025 | 42.00% |
| Jun 30, 2025 | 50.33% |
| Mar 31, 2025 | 59.10% |
| Dec 31, 2024 | 47.80% |
| Sep 30, 2024 | 32.55% |
| Jun 30, 2024 | -17.84% |
| Mar 31, 2024 | 47.72% |
| Dec 31, 2023 | -16.85% |
| Sep 30, 2023 | -15.78% |
| Jun 30, 2023 | -17.51% |
| Mar 31, 2023 | 40.55% |
| Dec 31, 2022 | -39.21% |
| Sep 30, 2022 | -1.00% |
| Jun 30, 2022 | -17.12% |
| Mar 31, 2022 | 22.07% |
| Dec 31, 2021 | -3.33% |
| Sep 30, 2021 | 60.13% |